The Prescription Drug Abuse Epidemic: Incidence, Treatment, Prevention, and Policy
byTy S. Schepis, PhD, is associate professor of psychology at Texas State University. He has been principal investigator on over $1 million in research grants from the National Institute on Drug Abuse.
-
eBook
9781440852657
MLA
Ty S. Schepis, PhD. The Prescription Drug Abuse Epidemic: Incidence, Treatment, Prevention, and Policy. Praeger, 2018. ABC-CLIO, publisher.abc-clio.com/9781440852657.
Chicago Manual of Style
Ty S. Schepis, PhD. The Prescription Drug Abuse Epidemic: Incidence, Treatment, Prevention, and Policy. Praeger, 2018. http://publisher.abc-clio.com/9781440852657
APA
Ty S. Schepis, PhD. (2018). The Prescription Drug Abuse Epidemic: Incidence, Treatment, Prevention, and Policy. Retrieved from http://publisher.abc-clio.com/9781440852657
- Description
-
This overview of prescription drug abuse includes historical background, key concepts, and discussion of the prevalence of drug abuse, treatments, and policy issues implicated in ending the epidemic.
• Zooms in on legal and policy issues related to the ongoing opioid epidemic in the U.S., providing insight into current and potential actions to limit the epidemic• Describes each prescription drug among the most commonly abused, for what it is prescribed, how it works, economic cost, and the damage that abuse of the drug may cause to both individual health and social wellbeing
• Identifies each of the most common groups of people who abuse prescription drugs, their motivations for doing so, and the special risks for each
• Addresses commonly co-abused drugs and the risks of using them concurrently
• Includes comparative text examining prescription drug abuse in Canada and the United Kingdom
- Table of Contents
-
Table of Contents
The Prescription Drug Abuse Epidemic: Incidence, Treatment, Prevention, and Policy
Author(s): Ty S. Schepis, PhDContributors: Schepis, Ty;Abstract:This overview of prescription drug abuse includes historical background, key concepts, and discussion of the prevalence of drug abuse, treatments, and policy issues implicated in ending the epidemic.
• Zooms in on legal and policy issues related to the ongoing opioid epidemic in the U.S., providing insight into current and potential actions to limit the epidemic• Describes each prescription drug among the most commonly abused, for what it is prescribed, how it works, economic cost, and the damage that abuse of the drug may cause to both individual health and social wellbeing
• Identifies each of the most common groups of people who abuse prescription drugs, their motivations for doing so, and the special risks for each
• Addresses commonly co-abused drugs and the risks of using them concurrently
• Includes comparative text examining prescription drug abuse in Canada and the United Kingdom
Editor(s): Schepis, Ty;SortTitle: prescription drug abuse epidemic: incidence, treatment, prevention, and policyAuthor Info:Ty S. Schepis Ph.D.editorTy S. Schepis, PhD, is associate professor of psychology at Texas State University. He has been principal investigator on over $1 million in research grants from the National Institute on Drug Abuse.
eISBN-13: 9781440852657Cover Image URL: ~~FreeAttachments/9781440852657.jpgPrint ISBN-13: 9781440852640Imprint: PraegerPages: 336Publication Date: 20180630Table of Contents pages: 1 2
- Cover Cover11
- Title iii4
- Copyright iv5
- Contents v6
- Acknowledgments vii8
- Chapter 1: Introduction 110
- Chapter 2: Opioids 615
- Chapter 3: Stimulants 3140
- Chapter 4: Benzodiazepines 4756
- Chapter 5: Misuse and Abuse of Over-the-Counter Medicines 6978
- Chapter 6: Nonmedical Prescription Drug Use in Adolescents and Young Adults 8392
- Health Burden of Nonmedical Prescription Drug Use in the United States 8594
- Nonmedical Prescription Opioid Use (NMPO) 8695
- Nonmedical Prescription Stimulant Use (NMPS) 92101
- Nonmedical Use of Prescription Tranquilizers and Sedatives 97106
- Historical Trends among Adolescents 97106
- Public Health Significance and Correlates of Nonmedical Prescription Tranquilizer and Sedative Use among Adolescents 98107
- Historical Trends among Young Adults 100109
- Public Health Significance and Correlates of Nonmedical Prescription Tranquilizer\and Sedative Use among Young Adults 101110
- Conclusion 104113
- References 105114
- Chapter 7: Misuse of Prescription Drugs among Young Adults 115124
- Chapter 8: Prescription Drug Misuse in Older Adults 133142
- Opioid Epidemic in the United States 134143
- Overdose Death 135144
- Opioid Misuse in Older Adults 135144
- Prescription Opioid Misuse in Older Adults with Chronic Nonmalignant Pain 136145
- Use of Benzodiazepines in Older Adults 137146
- Impact of Prescription Opioid Misuse in Older Adults 138147
- Correlates of Prescription Opioid Misuse 138147
- Behavioral Intervention to Reduce Prescription Opioid Misuse in Older Adults 140149
- Strategies for Successful Management of Chronic Pain while Mitigating Opioid Misuse 142151
- Conclusion 142151
- References 143152
- Chapter 9: Opioids: Misuse and Guideline-Concordant Use in Pain Management 150159
- Chapter 10: Opioids in the Emergency Setting 164173
- Opioids for Acute Pain 165174
- Opioids and Chronic Pain 166175
- Risk of Use 168177
- Responsible Prescribing Practices 170179
- Pain Management in Patients with Substance Use Disorders 172181
- Alternatives and Nonopioid Adjuncts 174183
- Best Practices in Opioid Overdose 178187
- Conclusion 180189
- References 181190
- Chapter 11: Regulation of Opioid Medications in the United States 193202
- Opioid Problem in the United States 193202
- Government Regulations 195204
- Regulatory Response to the Current Opioid Problem in the United States 196205
- Prescription Drug Monitoring Programs (PDMPs) 199208
- Urine Drug Screening 199208
- Transitions of Care in Chronic Opioid Management 201210
- Conclusion 202211
- References 203212
- Chapter 12: Promoting Prescription Drug Monitoring Programs for Population Health: Research and Policy Implications 206215
- Development of the Modern PDMP 207216
- Prescription Drug Monitoring Programs and Population Health 211220
- Effect of PDMPs on Prescribing Behavior 211220
- Attenuated Effect of PDMPs on Opioid Prescribing 213222
- Effect of PDMPs on Population Health 214223
- Nonfatal Drug-Related Overdose 215224
- Fatal Drug-Related Overdose 215224
- Prescription Drug Monitoring Programs: Operational Characteristics 217226
- Can PDMPs Have Unintended Negative Consequences? 218227
- Prescription Drug Monitoring Programs and Health Disparities 219228
- Challenges in Existing Research and Directions for Future Research 220229
- Conclusions 221230
- Acknowledgments 221230
- References 221230
- Chapter 13: Harm Reduction Approaches to Opioids 227236
- Chapter 14: A Comparison of Recent Trends in Prescription Drug Misuse in the United States and the United Kingdom 242251
- Trends in the United Kingdom 244253
- Trends in the General Population 244253
- Trends in Individuals Presenting to Treatment Agencies 245254
- Trends among Prisoners 245254
- Trends in Drug-Related Deaths 246255
- Trends in the Number of Prescriptions Dispensed in the Community 247256
- Trends in Seizures of Prescription Drugs 248257
- Summary of PDM Trends in the United Kingdom 249258
- Trends in the United States 250259
- Trends in the General Population 250259
- Trends in Individuals Presenting to Treatment Agencies 251260
- Trends among Prisoners 251260
- Trends in Drug-Related Deaths 252261
- Trends in the Number of Prescriptions Dispensed in the Community 253262
- Trends in Seizures of Prescription Drugs 253262
- Summary of PDM Trends in the United States 254263
- PDM Trends in the United States and United Kingdom Compared 254263
Table of Contents pages: 1 2